Key statistics
As of last trade, Biomea Fusion Inc (BMEA:NSQ) traded at 1.28, 46.23% above the 52 week low of 0.8719 set on Nov 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.36 |
|---|---|
| High | 1.37 |
| Low | 1.26 |
| Bid | 1.27 |
| Offer | 1.28 |
| Previous close | 1.35 |
| Average volume | 1.36m |
|---|---|
| Shares outstanding | 70.70m |
| Free float | 65.00m |
| P/E (TTM) | -- |
| Market cap | 95.45m USD |
| EPS (TTM) | -2.39 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 16:14 GMT.
More ▼
Announcements
- Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
- Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
- Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
- Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
- Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Biomea Fusion to Participate at Upcoming Investor Conferences
- Biomea Fusion to Participate at Jefferies London Healthcare Conference
- Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
- Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
More ▼
